Correlation Between Oncotelic Therapeutics and Biotron

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncotelic Therapeutics and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncotelic Therapeutics and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncotelic Therapeutics and Biotron Limited, you can compare the effects of market volatilities on Oncotelic Therapeutics and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncotelic Therapeutics with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncotelic Therapeutics and Biotron.

Diversification Opportunities for Oncotelic Therapeutics and Biotron

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Oncotelic and Biotron is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Oncotelic Therapeutics and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Oncotelic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncotelic Therapeutics are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Oncotelic Therapeutics i.e., Oncotelic Therapeutics and Biotron go up and down completely randomly.

Pair Corralation between Oncotelic Therapeutics and Biotron

If you would invest  2.20  in Oncotelic Therapeutics on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Oncotelic Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.4%
ValuesDaily Returns

Oncotelic Therapeutics  vs.  Biotron Limited

 Performance 
       Timeline  
Oncotelic Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncotelic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Oncotelic Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Biotron Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotron Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Oncotelic Therapeutics and Biotron Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncotelic Therapeutics and Biotron

The main advantage of trading using opposite Oncotelic Therapeutics and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncotelic Therapeutics position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.
The idea behind Oncotelic Therapeutics and Biotron Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum